Drug reduces seizure frequency in children with tuberous sclerosis complex

(Cincinnati Children's Hospital Medical Center) In an international study, the drug everolimus has been shown to significantly reduce the frequency of seizures in patients with treatment-resistant epilepsy and tuberous sclerosis complex (TSC) -- a genetic disease that causes malformations and tumors in the brain and other vital organs.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news